title: Hypersensitivity reaction to epirubicin.
abstract: A patient with metastatic breast cancer treated with epirubicin (Pharmorubicin) developed a severe urticarial reaction which progressed to ulceration following possible sensitisation to the drug by preceding extravasation.
authors.affiliation: CRC Department of Medical Oncology, University of Glasgow, U.K.
authors.forename: J
authors.initials: J
authors.lastname: Cassidy
authors.forename: E M
authors.initials: EM
authors.lastname: Rankin
mesh_terms: D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000150:complications; D004342:Drug Hypersensitivity; D015251:Epirubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005119:Extravasation of Diagnostic and Therapeutic Materials; D005260:Female; D006801:Humans; D008875:Middle Aged
chemical_list: D015251:Epirubicin